Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 2161 to 2170 of 2170 entries
Sorted by: Best Match Show Resources per page
Correction: Cortical organoids model early brain development disrupted by 16p11.2 copy number variants in autism.

Molecular psychiatry

Urresti J, Zhang P, Moran-Losada P, Yu NK, Negraes PD, Trujillo CA, Antaki D, Amar M, Chau K, Pramod AB, Diedrich J, Tejwani L, Romero S, Sebat J, Yates Iii JR, Muotri AR, Iakoucheva LM.
PMID: 34548630
Mol Psychiatry. 2021 Sep 21; doi: 10.1038/s41380-021-01289-6. Epub 2021 Sep 21.

No abstract available.

Cite
Urresti J, Zhang P, Moran-Losada P, et al. Correction: Cortical organoids model early brain development disrupted by 16p11.2 copy number variants in autism. Mol Psychiatry. 2021;doi: 10.1038/s41380-021-01289-6.
Urresti, J., Zhang, P., Moran-Losada, P., Yu, N. K., Negraes, P. D., Trujillo, C. A., Antaki, D., Amar, M., Chau, K., Pramod, A. B., Diedrich, J., Tejwani, L., Romero, S., Sebat, J., Yates Iii, J. R., Muotri, A. R., & Iakoucheva, L. M. (2021). Correction: Cortical organoids model early brain development disrupted by 16p11.2 copy number variants in autism. Molecular psychiatry, . https://doi.org/10.1038/s41380-021-01289-6
Urresti, Jorge, et al. "Correction: Cortical organoids model early brain development disrupted by 16p11.2 copy number variants in autism." Molecular psychiatry vol. (2021). doi: https://doi.org/10.1038/s41380-021-01289-6
Urresti J, Zhang P, Moran-Losada P, Yu NK, Negraes PD, Trujillo CA, Antaki D, Amar M, Chau K, Pramod AB, Diedrich J, Tejwani L, Romero S, Sebat J, Yates Iii JR, Muotri AR, Iakoucheva LM. Correction: Cortical organoids model early brain development disrupted by 16p11.2 copy number variants in autism. Mol Psychiatry. 2021 Sep 21; doi: 10.1038/s41380-021-01289-6. Epub 2021 Sep 21. PMID: 34548630.
Copy Download .nbib Format: NLM
Clinical Outcomes of Severe COVID-19 Patients Admitted to an Intermediate Respiratory Care Unit.

Frontiers in medicine

Suarez-Cuartin G, Gasa M, Bermudo G, Ruiz Y, Hernandez-Argudo M, Marin A, Trias-Sabria P, Cordoba A, Cuevas E, Sarasate M, Ariza A, Sabater J, Romero N, Subirana C, Molina-Molina M, Santos S.
PMID: 34277674
Front Med (Lausanne). 2021 Jul 01;8:711027. doi: 10.3389/fmed.2021.711027. eCollection 2021.

No abstract available.

Cite
Suarez-Cuartin G, Gasa M, Bermudo G, et al. Clinical Outcomes of Severe COVID-19 Patients Admitted to an Intermediate Respiratory Care Unit. Front Med (Lausanne). 2021;8:711027doi: 10.3389/fmed.2021.711027.
Suarez-Cuartin, G., Gasa, M., Bermudo, G., Ruiz, Y., Hernandez-Argudo, M., Marin, A., Trias-Sabria, P., Cordoba, A., Cuevas, E., Sarasate, M., Ariza, A., Sabater, J., Romero, N., Subirana, C., Molina-Molina, M., & Santos, S. (2021). Clinical Outcomes of Severe COVID-19 Patients Admitted to an Intermediate Respiratory Care Unit. Frontiers in medicine, 8711027. https://doi.org/10.3389/fmed.2021.711027
Suarez-Cuartin, Guillermo, et al. "Clinical Outcomes of Severe COVID-19 Patients Admitted to an Intermediate Respiratory Care Unit." Frontiers in medicine vol. 8 (2021): 711027. doi: https://doi.org/10.3389/fmed.2021.711027
Suarez-Cuartin G, Gasa M, Bermudo G, Ruiz Y, Hernandez-Argudo M, Marin A, Trias-Sabria P, Cordoba A, Cuevas E, Sarasate M, Ariza A, Sabater J, Romero N, Subirana C, Molina-Molina M, Santos S. Clinical Outcomes of Severe COVID-19 Patients Admitted to an Intermediate Respiratory Care Unit. Front Med (Lausanne). 2021 Jul 01;8:711027. doi: 10.3389/fmed.2021.711027. eCollection 2021. PMID: 34277674; PMCID: PMC8280318.
Copy Download .nbib Format: NLM
Differential strategies of two species of arbuscular mycorrhizal fungi in the protection of maize plants grown in chromium-contaminated soils.

Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine

de Los Angeles Beltrán-Nambo M, Rojas-Jacuinde N, Martínez-Trujillo M, Jaramillo-López PF, Romero MG, Carreón-Abud Y.
PMID: 34417897
Biometals. 2021 Dec;34(6):1247-1261. doi: 10.1007/s10534-021-00340-x. Epub 2021 Aug 21.

Chromium (Cr) is a nonessential element for plants that is extremely toxic at high concentrations. Zea mays L. is a species of plant that has developed adaptive mechanisms to increase its tolerance and absorption capacity for this metal. One...

Cite
de Los Angeles Beltrán-Nambo M, Rojas-Jacuinde N, Martínez-Trujillo M, et al. Differential strategies of two species of arbuscular mycorrhizal fungi in the protection of maize plants grown in chromium-contaminated soils. Biometals. 2021;34(6):1247-1261doi: 10.1007/s10534-021-00340-x.
de Los Angeles Beltrán-Nambo, M., Rojas-Jacuinde, N., Martínez-Trujillo, M., Jaramillo-López, P. F., Romero, M. G., & Carreón-Abud, Y. (2021). Differential strategies of two species of arbuscular mycorrhizal fungi in the protection of maize plants grown in chromium-contaminated soils. Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 34(6), 1247-1261. https://doi.org/10.1007/s10534-021-00340-x
de Los Angeles Beltrán-Nambo, Maria, et al. "Differential strategies of two species of arbuscular mycorrhizal fungi in the protection of maize plants grown in chromium-contaminated soils." Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine vol. 34,6 (2021): 1247-1261. doi: https://doi.org/10.1007/s10534-021-00340-x
de Los Angeles Beltrán-Nambo M, Rojas-Jacuinde N, Martínez-Trujillo M, Jaramillo-López PF, Romero MG, Carreón-Abud Y. Differential strategies of two species of arbuscular mycorrhizal fungi in the protection of maize plants grown in chromium-contaminated soils. Biometals. 2021 Dec;34(6):1247-1261. doi: 10.1007/s10534-021-00340-x. Epub 2021 Aug 21. PMID: 34417897.
Copy Download .nbib Format: NLM
Effect of osteopathic manipulation on gait asymmetry.

Journal of osteopathic medicine

Hill CN, Romero M, Rogers M, Queen RM, Brolinson PG.
PMID: 34787381
J Osteopath Med. 2021 Nov 18; doi: 10.1515/jom-2021-0046. Epub 2021 Nov 18.

CONTEXT: Movement and loading asymmetry are associated with an increased risk of musculoskeletal injury, disease progression, and suboptimal recovery. Osteopathic structural screening can be utilized to determine areas of somatic dysfunction that could contribute to movement and loading asymmetry....

Cite
Hill CN, Romero M, Rogers M, et al. Effect of osteopathic manipulation on gait asymmetry. J Osteopath Med. 2021;doi: 10.1515/jom-2021-0046.
Hill, C. N., Romero, M., Rogers, M., Queen, R. M., & Brolinson, P. G. (2021). Effect of osteopathic manipulation on gait asymmetry. Journal of osteopathic medicine, . https://doi.org/10.1515/jom-2021-0046
Hill, Cherice N, et al. "Effect of osteopathic manipulation on gait asymmetry." Journal of osteopathic medicine vol. (2021). doi: https://doi.org/10.1515/jom-2021-0046
Hill CN, Romero M, Rogers M, Queen RM, Brolinson PG. Effect of osteopathic manipulation on gait asymmetry. J Osteopath Med. 2021 Nov 18; doi: 10.1515/jom-2021-0046. Epub 2021 Nov 18. PMID: 34787381.
Copy Download .nbib Format: NLM
Proteomic signatures predict preeclampsia in individual cohorts but not across cohorts - implications for clinical biomarker studies.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians

Ghaemi MS, Tarca AL, Romero R, Stanley N, Fallahzadeh R, Tanada A, Culos A, Ando K, Han X, Blumenfeld YJ, Druzin ML, El-Sayed YY, Gibbs RS, Winn VD, Contrepois K, Ling XB, Wong RJ, Shaw GM, Stevenson DK, Gaudilliere B, Aghaeepour N, Angst MS.
PMID: 33653202
J Matern Fetal Neonatal Med. 2021 Mar 02;1-8. doi: 10.1080/14767058.2021.1888915. Epub 2021 Mar 02.

BACKGROUND: Early identification of pregnant women at risk for preeclampsia (PE) is important, as it will enable targeted interventions ahead of clinical manifestations. The quantitative analyses of plasma proteins feature prominently among molecular approaches used for risk prediction. However,...

Cite
Ghaemi MS, Tarca AL, Romero R, et al. Proteomic signatures predict preeclampsia in individual cohorts but not across cohorts - implications for clinical biomarker studies. J Matern Fetal Neonatal Med. 2021;1-8doi: 10.1080/14767058.2021.1888915.
Ghaemi, M. S., Tarca, A. L., Romero, R., Stanley, N., Fallahzadeh, R., Tanada, A., Culos, A., Ando, K., Han, X., Blumenfeld, Y. J., Druzin, M. L., El-Sayed, Y. Y., Gibbs, R. S., Winn, V. D., Contrepois, K., Ling, X. B., Wong, R. J., Shaw, G. M., Stevenson, D. K., Gaudilliere, B., Aghaeepour, N., & Angst, M. S. (2021). Proteomic signatures predict preeclampsia in individual cohorts but not across cohorts - implications for clinical biomarker studies. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 1-8. https://doi.org/10.1080/14767058.2021.1888915
Ghaemi, Mohammad S, et al. "Proteomic signatures predict preeclampsia in individual cohorts but not across cohorts - implications for clinical biomarker studies." The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians vol. (2021): 1-8. doi: https://doi.org/10.1080/14767058.2021.1888915
Ghaemi MS, Tarca AL, Romero R, Stanley N, Fallahzadeh R, Tanada A, Culos A, Ando K, Han X, Blumenfeld YJ, Druzin ML, El-Sayed YY, Gibbs RS, Winn VD, Contrepois K, Ling XB, Wong RJ, Shaw GM, Stevenson DK, Gaudilliere B, Aghaeepour N, Angst MS. Proteomic signatures predict preeclampsia in individual cohorts but not across cohorts - implications for clinical biomarker studies. J Matern Fetal Neonatal Med. 2021 Mar 02;1-8. doi: 10.1080/14767058.2021.1888915. Epub 2021 Mar 02. PMID: 33653202; PMCID: PMC8410912.
Copy Download .nbib Format: NLM
Effective presence of antibodies against common human coronavirus in IgG immunoglobulin medicinal products.: Antibodies to common coronaviruses in IgG medicinal products.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Díez JM, Romero C, Gajardo R.
PMID: 34929360
Int J Infect Dis. 2021 Dec 17; doi: 10.1016/j.ijid.2021.12.329. Epub 2021 Dec 17.

BACKGROUND: In these studies, immunoglobulin (IgG) products (IV, IM, SC) prepared from geographically diverse plasma pools were tested for activity against common human coronaviruses (HCoV). Products from plasma obtained from Germany, Czech Republic, Slovak Republic, USA, and Spain were...

Cite
Díez JM, Romero C, Gajardo R. Effective presence of antibodies against common human coronavirus in IgG immunoglobulin medicinal products.: Antibodies to common coronaviruses in IgG medicinal products. Int J Infect Dis. 2021;doi: 10.1016/j.ijid.2021.12.329.
Díez, J. M., Romero, C., & Gajardo, R. (2021). Effective presence of antibodies against common human coronavirus in IgG immunoglobulin medicinal products.: Antibodies to common coronaviruses in IgG medicinal products. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, . https://doi.org/10.1016/j.ijid.2021.12.329
Díez, José María, et al. "Effective presence of antibodies against common human coronavirus in IgG immunoglobulin medicinal products.: Antibodies to common coronaviruses in IgG medicinal products." International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases vol. (2021). doi: https://doi.org/10.1016/j.ijid.2021.12.329
Díez JM, Romero C, Gajardo R. Effective presence of antibodies against common human coronavirus in IgG immunoglobulin medicinal products.: Antibodies to common coronaviruses in IgG medicinal products. Int J Infect Dis. 2021 Dec 17; doi: 10.1016/j.ijid.2021.12.329. Epub 2021 Dec 17. PMID: 34929360; PMCID: PMC8679496.
Copy Download .nbib Format: NLM
Rapid interrogation of cancer cell of origin through CRISPR editing.

Proceedings of the National Academy of Sciences of the United States of America

Feng W, Cao Z, Lim PX, Zhao H, Luo H, Mao N, Lee YS, Rivera AA, Choi D, Wu C, Han T, Romero R, de Stanchina E, Carver BS, Wang Q, Jasin M, Sawyers CL.
PMID: 34353917
Proc Natl Acad Sci U S A. 2021 Aug 10;118(32). doi: 10.1073/pnas.2110344118.

The increasing complexity of different cell types revealed by single-cell analysis of tissues presents challenges in efficiently elucidating their functions. Here we show, using prostate as a model tissue, that primary organoids and freshly isolated epithelial cells can be...

Cite
Feng W, Cao Z, Lim PX, et al. Rapid interrogation of cancer cell of origin through CRISPR editing. Proc Natl Acad Sci U S A. 2021;118(32)doi: 10.1073/pnas.2110344118.
Feng, W., Cao, Z., Lim, P. X., Zhao, H., Luo, H., Mao, N., Lee, Y. S., Rivera, A. A., Choi, D., Wu, C., Han, T., Romero, R., de Stanchina, E., Carver, B. S., Wang, Q., Jasin, M., & Sawyers, C. L. (2021). Rapid interrogation of cancer cell of origin through CRISPR editing. Proceedings of the National Academy of Sciences of the United States of America, 118(32), . https://doi.org/10.1073/pnas.2110344118
Feng, Weiran, et al. "Rapid interrogation of cancer cell of origin through CRISPR editing." Proceedings of the National Academy of Sciences of the United States of America vol. 118,32 (2021). doi: https://doi.org/10.1073/pnas.2110344118
Feng W, Cao Z, Lim PX, Zhao H, Luo H, Mao N, Lee YS, Rivera AA, Choi D, Wu C, Han T, Romero R, de Stanchina E, Carver BS, Wang Q, Jasin M, Sawyers CL. Rapid interrogation of cancer cell of origin through CRISPR editing. Proc Natl Acad Sci U S A. 2021 Aug 10;118(32). doi: 10.1073/pnas.2110344118. PMID: 34353917; PMCID: PMC8364185.
Copy Download .nbib Format: NLM
Lack of Mucosal Cholinergic Innervation Is Associated With Increased Risk of Enterocolitis in Hirschsprung's Disease.

Cellular and molecular gastroenterology and hepatology

Keck S, Galati-Fournier V, Kym U, Moesch M, Usemann J, Müller I, Subotic U, Tharakan SJ, Krebs T, Stathopoulos E, Schmittenbecher P, Cholewa D, Romero P, Reingruber B, Bruder E, Group NS, Holland-Cunz S.
PMID: 33741501
Cell Mol Gastroenterol Hepatol. 2021;12(2):507-545. doi: 10.1016/j.jcmgh.2021.03.004. Epub 2021 Mar 16.

BACKGROUND & AIMS: Hirschsprung's disease (HSCR) is a congenital intestinal motility disorder defined by the absence of enteric neuronal cells (ganglia) in the distal gut. The development of HSCR-associated enterocolitis remains a life-threatening complication. Absence of enteric ganglia implicates...

Cite
Keck S, Galati-Fournier V, Kym U, et al. Lack of Mucosal Cholinergic Innervation Is Associated With Increased Risk of Enterocolitis in Hirschsprung's Disease. Cell Mol Gastroenterol Hepatol. 2021;12(2):507-545doi: 10.1016/j.jcmgh.2021.03.004.
Keck, S., Galati-Fournier, V., Kym, U., Moesch, M., Usemann, J., Müller, I., Subotic, U., Tharakan, S. J., Krebs, T., Stathopoulos, E., Schmittenbecher, P., Cholewa, D., Romero, P., Reingruber, B., Bruder, E., Group, N. S., & Holland-Cunz, S. (2021). Lack of Mucosal Cholinergic Innervation Is Associated With Increased Risk of Enterocolitis in Hirschsprung's Disease. Cellular and molecular gastroenterology and hepatology, 12(2), 507-545. https://doi.org/10.1016/j.jcmgh.2021.03.004
Keck, Simone, et al. "Lack of Mucosal Cholinergic Innervation Is Associated With Increased Risk of Enterocolitis in Hirschsprung's Disease." Cellular and molecular gastroenterology and hepatology vol. 12,2 (2021): 507-545. doi: https://doi.org/10.1016/j.jcmgh.2021.03.004
Keck S, Galati-Fournier V, Kym U, Moesch M, Usemann J, Müller I, Subotic U, Tharakan SJ, Krebs T, Stathopoulos E, Schmittenbecher P, Cholewa D, Romero P, Reingruber B, Bruder E, Group NS, Holland-Cunz S. Lack of Mucosal Cholinergic Innervation Is Associated With Increased Risk of Enterocolitis in Hirschsprung's Disease. Cell Mol Gastroenterol Hepatol. 2021;12(2):507-545. doi: 10.1016/j.jcmgh.2021.03.004. Epub 2021 Mar 16. PMID: 33741501; PMCID: PMC8258990.
Copy Download .nbib Format: NLM
The price tag of a potential cure for chronic hepatitis B infection: A cost threshold analysis for USA, China and Australia.

Liver international : official journal of the International Association for the Study of the Liver

Toy M, Hutton D, McCulloch K, Romero N, Revill PA, Penicaud MC, So S, Cowie BC.
PMID: 34328697
Liver Int. 2021 Jul 30; doi: 10.1111/liv.15027. Epub 2021 Jul 30.

BACKGROUND & AIMS: We aim to capture the economic impact of a potential cure for chronic hepatitis B infection (CHB) in three countries (USA, China and Australia) with different health systems and epidemics to estimate the threshold drug prices...

Cite
Toy M, Hutton D, McCulloch K, et al. The price tag of a potential cure for chronic hepatitis B infection: A cost threshold analysis for USA, China and Australia. Liver Int. 2021;doi: 10.1111/liv.15027.
Toy, M., Hutton, D., McCulloch, K., Romero, N., Revill, P. A., Penicaud, M. C., So, S., & Cowie, B. C. (2021). The price tag of a potential cure for chronic hepatitis B infection: A cost threshold analysis for USA, China and Australia. Liver international : official journal of the International Association for the Study of the Liver, . https://doi.org/10.1111/liv.15027
Toy, Mehlika, et al. "The price tag of a potential cure for chronic hepatitis B infection: A cost threshold analysis for USA, China and Australia." Liver international : official journal of the International Association for the Study of the Liver vol. (2021). doi: https://doi.org/10.1111/liv.15027
Toy M, Hutton D, McCulloch K, Romero N, Revill PA, Penicaud MC, So S, Cowie BC. The price tag of a potential cure for chronic hepatitis B infection: A cost threshold analysis for USA, China and Australia. Liver Int. 2021 Jul 30; doi: 10.1111/liv.15027. Epub 2021 Jul 30. PMID: 34328697.
Copy Download .nbib Format: NLM
Carbon-Based Materials in Photodynamic and Photothermal Therapies Applied to Tumor Destruction.

International journal of molecular sciences

Lagos KJ, Buzzá HH, Bagnato VS, Romero MP.
PMID: 35008458
Int J Mol Sci. 2021 Dec 21;23(1). doi: 10.3390/ijms23010022.

Within phototherapy, a grand challenge in clinical cancer treatments is to develop a simple, cost-effective, and biocompatible approach to treat this disease using ultra-low doses of light. Carbon-based materials (CBM), such as graphene oxide (GO), reduced GO (r-GO), graphene...

Cite
Lagos KJ, Buzzá HH, Bagnato VS, et al. Carbon-Based Materials in Photodynamic and Photothermal Therapies Applied to Tumor Destruction. Int J Mol Sci. 2021;23(1)doi: 10.3390/ijms23010022.
Lagos, K. J., Buzzá, H. H., Bagnato, V. S., & Romero, M. P. (2021). Carbon-Based Materials in Photodynamic and Photothermal Therapies Applied to Tumor Destruction. International journal of molecular sciences, 23(1), . https://doi.org/10.3390/ijms23010022
Lagos, Karina J, et al. "Carbon-Based Materials in Photodynamic and Photothermal Therapies Applied to Tumor Destruction." International journal of molecular sciences vol. 23,1 (2021). doi: https://doi.org/10.3390/ijms23010022
Lagos KJ, Buzzá HH, Bagnato VS, Romero MP. Carbon-Based Materials in Photodynamic and Photothermal Therapies Applied to Tumor Destruction. Int J Mol Sci. 2021 Dec 21;23(1). doi: 10.3390/ijms23010022. PMID: 35008458.
Copy Download .nbib Format: NLM
Showing 2161 to 2170 of 2170 entries